Kotak Private Equity invested in Eyestem, a Bengaluru based cell therapy company. Eyestem has raised this funding from Kotak for using its patented flagship product, EyecyteRPE, to treat dry age-related macular degeneration through first in man clinical trials, according to the company’s press release.

Argus Partners advised Kotak Private Equity led by a team of partner Vinod Joseph, partner Suchita Ambadipudi, associate Protiti Basu, associate Anurag Prasad, associate Pranav Pillai and associate Mitali Jain.

2020-12-30

{incomplete}